AKT1 and renal cell carcinoma: Our study shows that SC66 inhibited cell viability, proliferation, migration and invasion in established (786-O and A498 lines) and primary human RCC cells.SC66 was found to inhibit AKT-mTORC1/2 activation and induce significant apoptosis in RCC cells.